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Abstract
Background:  Pseudomonas fluorescens is a ubiquitous Gram-negative bacterium frequently
encountered in hospitals as a contaminant of injectable material and surfaces. This psychrotrophic
bacterium, commonly described as unable to grow at temperatures above 32°C, is now considered
non pathogenic. We studied a recently identified clinical strain of P. fluorescens biovar I, MFN1032,
which is considered to cause human lung infection and can grow at 37°C in laboratory conditions.
Results: We found that MFN1032 secreted extracellular factors with a lytic potential at least as
high as that of MF37, a psychrotrophic strain of P. fluorescens or the mesophilic opportunistic
pathogen, Pseudomonas aeruginosa PAO1. We demonstrated the direct, and indirect – through
increases in biosurfactant release – involvement of a phospholipase C in the hemolytic activity of
this bacterium. Sequence analysis assigned this phospholipase C to a new group of phospholipases
C different from those produced by P. aeruginosa. We show that changes in PlcC production have
pleiotropic effects and that plcC overexpression and plcC extinction increase MFN1032 toxicity and
colonization, respectively.
Conclusion: This study provides the first demonstration that a PLC is involved in the secreted
hemolytic activity of a clinical strain of Pseudomonas fluorescens. Moreover, this phospholipase C
seems to belong to a complex biological network associated with the biosurfactant production.
Background
Pseudomonas fluorescens is a ubiquitous Gram-negative
bacterium frequently encountered in the environment.
Naturally resistant to a wide range of antibiotics and dis-
infectants, this bacterium is commonly found in hospitals
as a contaminant of cleaning solutions and even injecta-
ble material [1]. This bacterium is characterized by its very
large genome, containing a large number of regulatory
genes conferring a very high potential to adapt to environ-
mental variation [2]. P. fluorescens is generally considered
psychrotrophic species, but the presence of this bacterium
in hospitals has long been demonstrated [3]. The broad
clinical spectrum of this bacterium, which may colonize
the airways [4], urinary tract [5] and blood [6] of immu-
nocompromised patients and previously healthy patients,
demonstrates that human body temperature is not neces-
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sarily a barrier to the development of this microorganism.
These findings strongly suggest that different strains have
evolved to deal with this specific environment [7]. Previ-
ous investigations of the infectious potential of P. fluores-
cens  have demonstrated that this bacterium can bind
specifically to the cytoplasmic membrane of neurons and
glial cells [8]. Attachment to the cytoplasmic membrane
of the host cell is associated with the induction of apopto-
sis and necrosis [9]. LPS has clearly been implicated in
cytotoxicity, but other factors released along with LPS dur-
ing cytoadhesion also seem to be essential for the viru-
lence of this bacterium [10]. The virulence factors of
Pseudomonas aeruginosa and  Burkholderia  sp. have been
studied in detail, but little is known about those of P. flu-
orescens  [11,12].  P. fluorescens bacteria synthesize and
release various extracellular enzymes, including a protease
[13] and a lipase [14], which may be involved in viru-
lence. They also produce phospholipase C (PLC) [15-19]
– an enzyme produced by many bacterial pathogens and
associated with various levels of virulence [20]. The
pathophysiological role of secreted PLCs depends on bac-
terial species, extending from that of a major virulence fac-
tor to a minor metabolic factor involved in bacterial
survival or dissemination only, without cytotoxic effects
[21,22]. However, the effects of PLCs may be more subtle.
PLC interferes with eukaryotic cellular signaling cascades
and seems to be able to modulate the host immune
response [21]. Several members of the Pseudomonas family
produce PLCs [21], and the PLCs synthesized by P. aerugi-
nosa have been studied in detail [23]. The virulence poten-
tial of the PLCs of this bacterium has often been
associated with hemolytic activity [24]. Conversely, our
knowledge about hemolysin production by P. fluorescens
remains very limited. The PLCs identified in this species to
date have essentially been studied biochemically, without
considering their infectious potential.
We studied a recently identified strain of P. fluorescens
(MFN1032) [7] with mesophilic behavior and hemolytic
activity, comparing the cytotoxicity of the factors secreted
by this clinical strain with those secreted by the environ-
mental P. fluorescens strain MF37. We also included the
opportunistic pathogen P. aeruginosa in the study, as a ref-
erence. We identified a phospholipase C (PlcC) from
MFN1032 and compared its amino-acid sequence with
those of the PLCs produced by other P. fluorescens species
and other Gram-negative and Gram-positive bacteria. We
then evaluated the involvement of PlcC in the hemolytic
activity of MFN1032, by constructing plcC mutants.
Results
Characterization of the MFN1032 strain
MFN1032 has been isolated from the sputum of a patient
suffering from pneumonia. This bacterium has been char-
acterized as P. fluorescens biovar I by polyphasic taxonomy,
partial 16sRNA sequencing and siderotyping [7]. Cultura-
bility studies demonstrated that this strain was able to
grow (Figure 1A) and formed biofilms on polystyrene at
37°C. As PAO1, this bacterium shown strong beta-hemo-
lytic activity on sheep, horse or rabbit blood-agar plates
(Figure 1B), whereas strain MF37 was non-hemolytic.
MFN1032 also displayed lecithinase activity on egg-yolk
agar plates (Figure 1C).
Cytotoxic effects of bacterial culture supernatants
We assessed the cytotoxicity of supernatants from P. fluo-
rescens MFN1032, P. fluorescens MF37 and P. aeruginosa
PAO1 in two experimental models: LDH release from rat
Growth and extracellular activities of MFN1032 Figure 1
Growth and extracellular activities of MFN1032. A- Growth of MFN1032 on LB agar plates after 24 hours at 37°C. B- 
Secreted hemolytic activity of MFN1032 on sheep red blood agar plate after 48 hours of incubation at 28°C (1), and compari-
son with PAO1 (2) and MF37 (3). C- MFN1032 lecithinase activity on egg-yolk agar plate after 48 hours of incubation at 28°C.
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glial cells and the hemolysis of sheep erythrocytes in a liq-
uid assay.
We first investigated cytotoxicity in rat glial cells in pri-
mary culture, a model previously used to assess the cyto-
toxicity of P. aeruginosa and P. fluorescens [10]. Cell-free
supernatants from stationary growth phase cultures were
incubated overnight with primary cultures of rat glial
cells. MFN1032 and MF37 supernatants were much more
cytotoxic than those from the opportunistic pathogen
PAO1 at all growth temperatures studied (Figure 2A).
MFN1032 supernatants from bacteria grown at 17°C and
28°C were equally toxic (55% lysis), whereas those from
bacteria grown at 8°C were loss toxic (25% lysis). MF37
also displayed significantly higher levels of secreted cyto-
toxic activity against glial cells than PAO1 grown at 17°C
or 28°C. This activity was clearly temperature-dependent,
and was maximal at 17°C.
We monitored the levels of secreted hemolytic activity dis-
played by MFN1032 throughout bacterial growth.
MFN1032 grown at 17°C displayed hemolytic activity
only at the start of the stationary phase and similar pro-
files were observed at 8°C and 28°C. The kinetics of
hemolysin production by PAO1 was investigated only at
37°C. Hemolytic activity appeared to be stable after 15
bacterial generations in culture, in all the cases. These con-
ditions were therefore adopted in all subsequent studies.
Major differences were observed in the hemolytic activi-
ties of supernatants from cultures of MFN1032, MF37 and
PAO1 grown at 8, 17, 28 and 37°C (Figure 2B). Culture
supernatants from MF37 grown at 8, 17 and 28°C were
non hemolytic (no test was carried out at 37°C because
this strain cannot grow at this temperature). Hemolysis
levels for the clinical strain MFN1032 were maximal at
growth temperatures of 8 and 17°C (100% and 83% lysis,
respectively), and lower at 28°C (26% lysis). MFN1032
supernatants were non hemolytic if the bacteria were cul-
tured at 37°C. MFN1032 and PAO1 supernatants had
similar hemolytical potentials if the bacteria were grown
at 17°C (90% hemolysis) or 28°C (25% hemolysis) (Fig-
ure 2B). The hemolytic activity of PAO1 supernatants was
maximal at growth temperatures of 37°C (optimal
growth rate) and 17°C. By contrast, the secreted hemo-
lytic activity of the MFN1032 strain was not maximal at
the optimal growth rate for this strain (30°C).
As the P. fluorescens clinical strain MFN1032 displayed
hemolysis, we investigated the factors potentially
involved in this hemolytic activity.
Effect of growth temperature on the cytotoxicity of MFN1032 (white square), MF37 (grey square), and PAO1 (black square) Figure 2
Effect of growth temperature on the cytotoxicity of MFN1032 (white square), MF37 (grey square), and PAO1 
(black square). After 15 generations in LB medium, aliquots of cell-free supernatants were assayed for glial cell lysis (A) or 
hemolysis (B), as described in the materials and methods. For assays of glial cell cytotoxicity, supernatants were concentrated 
with an Amicon ultra-15 filter, and then resuspended in glial cell medium. Each experiment was performed at least three times 
in triplicate. Nd: not determined.
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Measurement of protease activity, LPS and biosurfactant 
release and lecithinase activity in the supernatant
No protease activity or LPS release (KDO level) into the
supernatants of MF37, MFN1032 and PAO1 cultured in
LB medium at 28°C was detected (Table 1). We used egg
yolk as a substrate for estimating PLC activity and biosur-
factant release was assessed with the drop-collapse test.
Both lecithinase activity and biosurfactant were detected
in these three culture supernatants, although higher levels
were observed for MFN1032 and PAO1 than for MF37
(Table 1).
Effect of D609 on the secreted hemolytic activity of 
MFN1032
We investigated the possible involvement of a secreted
PLC in the hemolytic activity of MFN1032 using D609,
which specifically inhibits certain PLCs [25]. Supernatants
from MFN1032 were incubated at room temperature for 1
h with D609 at a final concentration of 1 mM, and their
hemolytic activity was then assessed. Incubation with
D609 decreased hemolytic activity by 68% (Table 2).
Thus, a phospholipase C sensitive to D609 is clearly
involved in the hemolytic activity of MFN1032. By con-
trast, D609 treatment did not decrease the hemolytic
activity of PAO1 supernatants, consistent with previous
results [26].
Structural characterization of the PLC from MFN1032
SDS-PAGE and zymograms were used to determine the
apparent molecular mass of an enzyme with lecithinase
activity. A single band with lecithinase activity was recov-
ered from a silver-stained SDS-PAGE gel placed on an egg-
yolk agar plate (Figure 3). This protein had a molecular
mass of approximately 42 kDa. We designed PCR primers
based on the gene encoding a PLC of similar molecular
mass described by Preuss et al. and produced by an
uncharacterized P. fluorescens strain [15]. A single frag-
ment of 1.2 kb was obtained and cloned with the pMOS
kit. This fragment was sequenced by Genome Express
(France) and the sequence registered in the Genbank data-
base (accession number: DQ462712) named plcC. This
sequence encodes a predicted PlcC protein of 385 resi-
dues, with a molecular mass of 42 kDa. These findings are
consistent with SDS-PAGE and suggest that the protein is
secreted without cleavage. In silico analysis indicated the
absence of any known secretion signal sequence. No gene
amplification was obtained if the same primers were used
with MF37 and PAO1 (data not shown).
A search of the NCBI nucleotide and protein database
showed that the PLC from MFN1032 (PlcC) was very sim-
ilar to putative PLCs from other strains of P. fluorescens
(Table 3). The molecular mass of this group of PLCs
ranges from 42 kDa to 59 kDa. PlcC is clearly related to
the PLC described by Preuss et al. (98% identity), which
was produced by a P. fluorescens strain isolated as a con-
taminant of placental extract of unknown origin. These
two PLCs are also very similar to a putative PLC encoded
by the P. fluorescens SBW25 genome (92% identity), but
are more distantly related to the putative PLCs identified
for the Pf-5 strain – a rhizosphere strain of P. fluorescens
(76% identity) – and Pf0-1 (65% identity). Sequence
identity was also observed with putative PLCs from the
entomopathogen  Pseudomonas entomophila (68%) and
from Legionella pneumophila, although the level of identity
was lowers (43%). No significant similarity was observed
with the PLCs produced by P. aeruginosa (PlcH, PlcN and
PlcB) or with the PC-PLC from B. cereus (Table 3).
Construction of MFN1032 plcC mutants
The MFN1036 strain, a clone of MFN1032 that overex-
presses plcC, was obtained by electroporating MFN1032
with pUCP20, which carries the plcC gene and its pro-
moter (1.5 kb). The expression of plcC from this plasmid
was under the control of the constitutive plac promoter.
We investigated the involvement of PlcC in hemolytic
activity by culturing MFN1036 at 17°C and 28°C and
assessing its hemolytic activity in liquid assays. MFN1036
was significantly more cytotoxic (74% lysis at 28°C) than
the parental strain MFN1032 (26% lysis at 28°C) (Table
4). We used a plcC-deficient mutant, MFN1037, to deter-
mine whether PlcC contributed to the hemolytic activity
of MFN1032. We detected no hemolysis with MFN1037
culture supernatants, regardless of growth temperature
(Table 4). Complementation of the plcC mutation with
pMF36 (strain MFN1038) did not restore the hemolytic
phenotype of MFN1032 (Table 4), whereas it did result in
levels of lecithin degradation on egg-yolk agar plates sim-
ilar to those for the wild-type strain.
Table 1: Release of protease, LPS, lecithinase and biosurfactant 
into LB supernatants after growth at 28°C: (+: detection, -: no 
detection).
Strain Protease KDO Lecithinase BS
MFN1032 - - ++ ++
MF37 - - + +
PAO1 - - ++ ++
Table 2: Effect of D609 on the secreted hemolytic activities of 
MFN1032 and PAO1
% Hemolysis
D609 - +
Strain
MFN1032 92 ± 1 30 ± 3
PAO1 86 ± 1 85 ± 2BMC Microbiology 2008, 8:189 http://www.biomedcentral.com/1471-2180/8/189
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SDS-PAGE analysis of total extracellular proteins followed
by PlcC zymogram detection on egg-yolk agar plates
showed that there was no PlcC in the supernatant of cul-
tures of the plcC-deficient mutant MFN1037, as no leci-
thin degradation was observed (Figure 4, lane 2 and 5,
arrow a). The mutant released smaller amounts of an
approximately 50 kDa protein than did MFN1032 (arrow
b). Analysis of the amino-acid sequence of the N-terminus
of this protein (ALTVNTNIAS) suggested that it was a
homolog of the flagellin protein FliC produced by P. aer-
uginosa  and  P. putida. The plcC-complemented strain
MFN1038 displayed wild-type levels of lecithin degrada-
tion in zymogram analysis and a partial restoration of
flagellin levels (Figure 4, lanes 3 and 4, bands a and b
respectively). MFN1036 had an electrophoretic profile
identical to that of MFN1032, except for the 42 kDa pro-
tein previously identified as PlcC, which was produced in
larger amounts by MFN1036 (data not shown).
Pleiotropic effects of plcC gene mutation
Flagellin levels in the supernatant of the plcC-deficient
strain MFN1037 were low. We therefore investigated the
motility of the MFN1032 and the plcC mutants. In swim-
ming conditions (i.e 0.3% agar, final concentration),
MFN1036 completely invaded the plate over the course of
a 16 h incubation at 28°C and displayed swarming motil-
ity, whereas MFN1032 displayed only swimming motility
and diffused less (Figure 5B and 5A, respectively). This
may be due to higher levels of biosurfactant release or pro-
duction, than observed for the wild-type strain, as sug-
gested by the translucent appearance of the halo on the
plates. This hypothesis was confirmed by the drop-col-
Zymogram on egg-yolk agar of a silver-stained SDS-PAGE gel of MFN1032 supernatant Figure 3
Zymogram on egg-yolk agar of a silver-stained SDS-PAGE gel of MFN1032 supernatant. PLC activity was detected 
as an opaque band on the plate (arrow), the molecular mass of which was deduced. Concentrated MFN1032 supernatant was 
obtained following growth at 17°C in LB medium. 1: Front of a silver-stained gel placed on an egg-yolk agar plate (zymogram); 
2: corresponding silver-stained gel; 3: other side of the zymogram; M: molecular size markers.
94 -
67 -
43 -
30 -
1                      M                  2                      3BMC Microbiology 2008, 8:189 http://www.biomedcentral.com/1471-2180/8/189
Page 6 of 14
(page number not for citation purposes)
lapse test (Table 5). The plcC-deficient mutant MFN1037
and the complemented strain MFN1038 (not shown) had
swimming motility patterns similar to those of MFN1032
(Figure 5C), but did not produce biosurfactant on LB agar
plates, as shown by the drop-collapse test (Table 5). In
motility assays on LB plates containing 0.6% agar,
MFN1037 and MFN1038 had no swarming motility and
no movement was observed even after 40 h of growth at
28°C, whereas MFN1032 continued to be motile (Figure
5D and 5C, respectively).
The loss of biosurfactant production may be enough, in
itself, to account for the loss of swarming motility of the
plcC-deficient strain, but cannot account for the low levels
of flagellin release. Electron microscopy analyses of
MFN1032 and MFN1037 cells showed that the wild-type
strain had a single polar flagellum whereas the plcC-defi-
cient strain MFN1037 displayed a hyperflagellated pheno-
type, with most of the cells presenting three polar flagella
(Figure 6A and 6B, respectively). No difference in flagel-
lum size was observed, but these differences in flagella-
tion would probably affect the properties of the two
strains. MFN1037 cells formed aggregates on the grid,
whereas MFN1032 cells did not, despite having been pre-
pared in the same conditions. Adhesion was evaluated by
analyzing biofilm formation on polystyrene microarrays
at 37°C. We found that MFN1037 had a greater capacity
to form biofilms than the wild-type strain (255 ± 32%
more adhesion than MFN1032 at 37°C; Figure 6C).
Analysis of the flanking regions of plcC
We investigated the genomic organization of the genes
encoding PLCs in the genomes of P. fluorescens Pf0-1 and
Pf5. We identified two genes of unknown function in the
operon containing the plc gene in Pf0-1, and one in Pf5
(Figure 7). We found no other gene in an operon with plcC
in MFN1032, confirming that the pleiotropic effects of
plcC disruption could not be due to a polar mutation. No
gene encoding a potential flagellin or belonging to the
flagellar regulon were found in the surrounding region. A
gene encoding a putative dihydropycolinate synthase was
found in the 5' flanking region of plcC, in an antisense ori-
entation. In the 3' region, a similar phenomenon was
observed, except that the gene encoded a putative tran-
scriptional regulator of the GntR family [27]. This regula-
tor is probably involved in plcC expression because the
consensus GntR binding site (T.GT-N(0-3)-AC.A), as
identified by Rigali et al. [27], is present in the sequence
immediately upstream from the plcC gene.
Table 3: Comparison of the sequence of the MFN1032 PlcC with other PLC sequences
Strain PLC (ID Protein number) % Identity to PlcC Amino-acid residues MW (kDa)
P. fluorescens MFN1032 PlcC
(GI 92090692)
-3 8 5 4 2
P. fluorescens (Preuss) -
(GI 11611250)
98% 385 42
P. fluorescens SBW25 Putative 92% 383 42
P. fluorescens Pf-5 Putative
(GI 68342549)
76% 546 59
P. entomophila Putative
(GI 104780281)
68% 544 60
P. fluorescens Pf0-1 Putative
(GI 77380231)
65% 437 48
L. pneumophila PlcA
(GI 52627367)
43% 423 48
P. aeruginosa PlcH
(GI 15596041)
NS 730 79
P. aeruginosa PlcN
(GI 9949449)
NS 692 78
P. aeruginosa PlcB
(GI 9945846)
NS 328 37
B. cereus PC-PLC
(GI 28414376)
NS 283 28,5
NS: not significant
Table 4: Comparison of the secreted hemolytic activities of 
MFN1032 and the plcC mutants at various growth temperatures
Growth Temperature (°C) 81 7 2 8
Strain % Lysis
MFN1032 98 ± 1 83 ± 17 26 ± 3
MFN1036 Nd 100 ± 2 74 ± 13
MFN1037 2 ± 1 0.5 ± 0.1 0.8 ± 0.2
MFN1038 2 ± 1 0.4 ± 0.1 1 ± 0.2BMC Microbiology 2008, 8:189 http://www.biomedcentral.com/1471-2180/8/189
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Discussion
P. fluorescens is generally considered to be non pathogenic,
but its infectious potential has nonetheless been demon-
strated. In vitro studies of environmental strains, including
P. fluorescens MF37, have shown that this psychrotrophic
bacterium has most of the features of an opportunistic
pathogen [8]. P. fluorescens is a highly heterogeneous spe-
cies, ranging from avirulent strains that can be used in
crop protection [28] to clinical strains involved in lung,
urinary tract and blood infections. However, whereas the
low virulence of industrial strains has been studied in
detail, the factors involved in the virulence of clinical
forms of P. fluorescens, including MFN1032, have not pre-
viously been investigated. Virulence results from the com-
bined effects of direct contact between the bacterium and
the target cell and the production of many soluble or
SDS-PAGE of total extracellular proteins of MFN032 and the PlcC mutants MFN1037 and MFN1038 Figure 4
SDS-PAGE of total extracellular proteins of MFN032 and the PlcC mutants MFN1037 and MFN1038. Superna-
tants of cultures at 17°C in LB medium were concentrated on an Amicon ultra-15 filter and subjected to SDS-PAGE in a 10% 
acrylamide gel. The gel was silver-stained (lanes 1 to 3) and placed against an egg-yolk agar plate (lanes 4 to 6) to reveal lecithi-
nase activity (the opaque band on the plate). 1 and 6: MFN1032; 2 and 5: MFN1037 (plcC-deficient MFN1032); 3 and 4: 
MFN1038 (plcC complemented MFN1037). M- molecular size markers. a: PlcC; b: flagellin.
43
30
67 
94
a
b
M      1         2         3           4         5       6       MBMC Microbiology 2008, 8:189 http://www.biomedcentral.com/1471-2180/8/189
Page 8 of 14
(page number not for citation purposes)
secreted molecules and exotoxins acting at some distance
from the microorganism. MFN1032 has been shown to be
highly cytotoxic in vitro to eukaryotic cells, to which it
binds [7]. We investigated the role of factors secreted by
this bacterium in cytotoxicity. We therefore carried out
experiments with supernatants and culture medium
extracts only.
In addition to its ability to multiply at 37°C, which is
itself unusual for a strain of P. fluorescens, MFN1032 gen-
erated molecules with high levels of hemolytic and cyto-
toxic activity, as observed in in vitro models. The
hemolytic activity of MFN1032 supernatants was similar
to that of P. aeruginosa, which is an opportunistic patho-
gen. By contrast, a typical psychrotrophic strain, MF37,
displayed no hemolytic activity under the same condi-
tions. More surprisingly, MFN1032 supernatants were sig-
nificantly more cytotoxic to rat glial cells than PAO1
supernatants, for bacteria grown at 17°C and 28°C. The
secreted hemolytic and cytotoxic activities of P. fluorescens
MFN1032 and P. aeruginosa PAO1 appeared to be temper-
ature-dependent, as was P. fluorescens MF37 cytotoxicity.
Surprisingly, the supernatant of MFN1032 grown at 37°C
displayed no hemolysis. At first glance, this finding
appears to contradict the hypothesis that hemolysis is a
virulence factor. Low temperature induction likely reflects
the evolutionary history of the factors involved in this
activity and the function of those elements in non-infec-
tive conditions. In fact, it has been described that Pseu-
domonas aeruginosa from clinical and non-clinical
environments are genetically and functionally similar
[29,30]. So evolution of virulence determinants in oppor-
tunistic pathogens is not necessary linked to their interac-
tion with the human host. Finally, invasin and the heat-
stable enterotoxin Yst from Y. enterocolitica are also viru-
lence factors produced preferentially at temperatures
below 37°C in vitro. However, in conditions of slight acid-
ity or high osmolarity, these virulence genes are expressed
at 37°C in vitro. High-temperature repression may there-
fore be overcome by other conditions stimulating expres-
sion in the host.
Table 5: Evaluation of biosurfactant release into culture 
supernatants by the drop-collapse test
Strain BS Production
MFN1032 ++
MFN1036 +++
MFN1037 -
MFN1038 -
+: detection; -: no detection
Motility assays for MFN1032, MFN1036 and MFN1037 Figure 5
Motility assays for MFN1032, MFN1036 and MFN1037. The swimming motility of MFN1032 (A), MFN1036 (B) and 
MFN1037 (C) on 0.3% LB agar plates and the swarming motility of MFN1032 (D) and MFN1037 (E) on 0.6% LB agar plates 
after 16 h of incubation at 28°C. MFN1032 (wild type) and MFN1037 (plcC-deficient MFN1032) presented concentric halos on 
0.3% agar, corresponding to swimming motility, wherease MFN1036 (plcC-overexpressing MFN1032) displayed a dendritic pat-
tern indicative of swarming motility. The same pattern of MFN1037 mobility was obtained with strain MFN1038 (data not 
shown).
AB C DE
LB 0.3% agar (swimming) LB 0.6% agar (swarming)BMC Microbiology 2008, 8:189 http://www.biomedcentral.com/1471-2180/8/189
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We found that neither protease nor LPS was responsible
for the extracellular hemolytic activity of MFN1032. The
absence of protease activity in these conditions was not
surprising, as protease activity has been recovered from P.
aeruginosa PAO1 only after at least 18 h of growth in LB
medium and has never been observed with P. fluorescens
MF0 in this medium [13]. Many pathogens display
secreted hemolytic activity, which may be due to toxins,
biosurfactants, and/or enzymes (essentially PLCs) [31].
Various species of Pseudomonas have been reported to pro-
duce hemolytic and/or non hemolytic PLCs [16,21,32].
The observed degradation of lecithin by MF37 on plates or
in supernatants is consistent with this bacterium produc-
ing a non hemolytic PLC other than PlcC, as no gene
amplification was observed with plcC primers. By con-
trast, the PLC produced by MFN1032 is involved in the
hemolytic activity of this strain, as shown by the inhibi-
tory effect of D609.
A protein with lecithinase activity was identified in
MFN1032 supernatants by an egg-yolk agar plate zymo-
gram method. This enzyme has a molecular mass of 42
kDa, as determined by SDS-PAGE. This apparent molecu-
lar mass is similar to that of previously described P. fluo-
rescens PLC enzymes [15,16,18] and those of the putative
PlcB [33] and PlcA produced by P. aeruginosa (Vasil et al.,
data communicated at the Pseudomonas Congress, 2005).
The PlcH and PlcN produced by P. aeruginosa have a
higher molecular mass [23].
Analysis of the sequence of the plcC gene indicated consid-
erable similarity between PlcC and putative PLCs identi-
Transmission electron microscopy (TEM) of MFN1032 (A) and MFN1037 (B) cells Figure 6
Transmission electron microscopy (TEM) of MFN1032 (A) and MFN1037 (B) cells. (C) Biofilm quantification of 
MFN1032 and MFN1037 after 24 h of growth at 37°C in a polystyrene microtiter plate. Biofilm formation was 
quantified as the percentage relative to that observed with MFN1032 grown at 37°C.
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fied in various strains of P. fluorescens including, in
particular, the PLC produced by a P. fluorescens isolated
from placental extract [15] and the putative PLC from
SBW25. This plcC gene was shorter than those predicted
for Pf0-1 and Pf5, and the main difference between the
protein encoded by this gene and Pf0-1 and Pf5 con-
cerned the N-terminus of the protein. It is unclear whether
plc genes are expressed in the other strains and it is possi-
ble that PLC production is not specific to adaptation to
human infection but was acquired to survive in other
environments.
No significant sequence similarity was found between the
group of PLCs described here and the well characterized
zinc-metallophospholipases C of Gram-positive bacteria.
This group of PLCs is also only very distantly related to the
enzymes described by Stonehouse et al., including the
PlcH and PlcN of P. aeruginosa [26]. The differences
between these enzymes concern not only their sequences,
but also their catalytic sites, as D609 has no effect on PlcH
activity [26]. The PlcC from MFN1032 also appears to be
different from PAO1 PlcB and PlcA [33]. Thus, although
P. fluorescens and P. aeruginosa are generally thought to be
closely related, they have different PLCs. Preuss et al.
reported an elegant, detailed biochemical characterization
of their PLC. Their data concerning iron requirement and
D609 susceptibility suggested the existence of a new class
of PLCs, to which MFN1032 PlcC might belong.
Neither PlcC nor the PLC studied by Preuss et al. has a sig-
nal peptide. These enzymes are therefore presumably
secreted by an unknown mechanism, whereas most PLCs
are secreted by the Tat or Sec pathways [33-35]. Several
phospholipases have been reported to belong to the flag-
ellar regulon [36] and to be secreted by the flagellar export
apparatus [37,38], a type-three secretion system [39], or
by the two-partner secretion (TPS) system [40]. For exam-
ple, the transcription and secretion of YplA, the phosphol-
ipase A1 of  Yersinia enterocolitica, are controlled by the
flagellar regulon [37]. Warren et al. suggested that an
amino-terminal secretion signal of about 20 amino acids
is required for YplA secretion, but did not identify a par-
ticular signal peptide motif [41]. Some PLCs have been
shown to be regulated by the flagellar regulon, but no evi-
dence has ever been published to suggest that PLCs may
affect the expression of this regulon. There is no evidence
to suggest that the PlcC of MFN1032 is secreted by the
flagellar apparatus, but the lower levels of flagellin in the
supernatant of the plcC-deficient mutant than in the
supernatant of the control or complemented strain
implies a close link between these two proteins. This
hypothesis is supported by in silico analysis, which identi-
fied a cluster of orthologous groups (COG) corresponding
to a flagellar hook motif in PlcC. It should be noted that
the lower levels of flagellin do not indicate the lack of flag-
ella. The mutant displayed swimming motility and TEM
observations of MFN1037 cells confirmed that flagella
were present.
We constructed a plcC-overexpressing mutant of
MFN1032, MFN1036, to investigate the involvement of
PlcC in hemolytic activity and we found that a higher level
of PlcC production by MFN1032 was associated with
higher levels of hemolytic activity. The loss of hemolytic
activity in the plcC-deficient strain MFN1037 confirmed
the involvement of this enzyme in hemolysis. Hemolytic
activity was not restored in the MFN1038 strain, which
overexpressed plcC, and extinction of the plcC gene had
also pleiotropic effects, particularly as concerns the release
of biosurfactant and flagellin. This was not due to a polar
mutation involving plcC  gene interruption, as the plcC
gene was not associated with any other gene in an operon
in the MFN1032 genome. Linares et al. described that the
presence of low antibiotics concentrations in the culture
media may induce changes in bacterial physiology (bio-
film, motility and cytotoxicity) [42]. Their data could
explain the phenotype change of the plcC  mutant
MFN1037, but we were not in conditions used by these
authors (i.e subinhibitory concentrations of antibiotics).
We probably disturb a complex regulatory network in
MFN1037, and this hypothesis is also supported by plcC
overexpression in MFN1036 resulting in the overproduc-
tion of biosurfactants, increasing swarming mobility.
Such complex regulatory systems often involve positive
and/or negative feedback loops [43]. GntR regulators have
been reported to maintain their own expression [44], so a
positive feedback loop regulating GntR levels may exist.
As previously reported, a simple change affecting a key
element of this kind of system might lead to epigenetic
modification [45]. Epigenetic switches, corresponding to
phenotype modifications, arise and may be transmitted
from a cell to its progeny in the absence of genetic modi-
fications. This type of regulation has been reported for the
cytotoxicity associated with the T3SS (type-three secretion
system) of P. aeruginosa. Transient expression of the ExsA
transcriptional regulator in non inducible strains leads to
the acquisition of a cytotoxic phenotype [46]. The artifi-
cial extinction of plcC in MFN1037 may have triggered
such an epigenetic switch.
Conclusion
These findings demonstrate that some P. fluorescens strains
have some of the key characteristics of opportunistic path-
ogens. We provide the first demonstration, to our knowl-
edge, of the involvement of a PLC in the secreted
hemolytic activity of a clinical strain of P. fluorescens
(MFN1032). We found that MFN1032 secretes a phos-
pholipase C homologous to a PLC from an uncharacter-
ized P. fluorescens strain previously studied biochemicallyBMC Microbiology 2008, 8:189 http://www.biomedcentral.com/1471-2180/8/189
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by Preuss. This enzyme belongs to a new group unrelated
to the PLCs produced by P. aeruginosa and seems to be
produced by a wide range of P. fluorescens strains,
although no homolog of the plcC gene was found in our
model strain, MF37. Further studies including strains of
different origins presenting hemolytic activity would clar-
ify these observations. However, although PlcC is not spe-
cific to clinical isolates, this enzyme is a potential
v i r u l e n c e  f a c t o r  a s  o u r  d a t a  s h o w  t h a t  t h i s  e n z y m e  i s
directly involved in the secreted hemolytic activity of
MFN1032, as demonstrated by the inhibitory effect of
D609. The direct involvement of PlcC in MFN1032 viru-
lence could be further demonstrated or excluded by stud-
ying in vivo models.
Results obtained with the plcC mutants also suggest that
this enzyme interferes with biosurfactant production,
which might also account for the higher levels of hemoly-
sis observed when plcC was overexpressed. The pleiotropic
phenotype resulting from plcC mutation or overexpres-
sion suggests that PlcC is involved in a regulatory net-
work. We are now investigating a possible role for the 3'
flanking region of plcC, corresponding to the putative
transcriptional regulator GntR, with the aim of determin-
ing the link between PlcC, GntR and biosurfactant pro-
duction.
Methods
Bacterial strains and culture conditions
The MFN1032 strain was collected from a patient suffer-
ing from pulmonary tract infection (expectoration) at a
hospital in Haute Normandie. This strain was the only bac-
terial contaminant in a normally sterile compartment and
was considered to be the cause of the infection. MFN1032
was identified as a P. fluorescens biovar I strain [7]. PAO1
is a P. aeruginosa strain widely used in laboratory studies
[47]. MF37 is a spontaneously rifampicin-resistant
mutant of the MF0 strain, a psychrotrophic strain of P. flu-
orescens  isolated from unpasteurized milk extensively
studied in our laboratory [48]. These bacteria were cul-
tured in Luria Bertani medium (LB), at various tempera-
tures between 8 and 37°C, with shaking at 180 rpm.
When necessary, 500 μg/mL mezlocillin or 40 μg/mL tet-
racycline was added. Bacterial density was determined by
measuring optical density at 580 nm (Spectronic 601
spectrophotometer).
Glial cell cytotoxicity assays
Cytotoxicity was assessed by quantifying lactate dehydro-
genase (LDH) release into the medium by cells, as this
release reflects levels of necrosis. Concentrated superna-
tants (10 μL/mL culture medium) from bacterial cultures
at various temperatures were incubated overnight with rat
glial cells (8 × 106 cells/mL) that had been cultured in vitro
for 12 days. Controls included LB concentrated with Ami-
con Ultra-15 centrifugal filter units and incubated for the
same period of time in culture medium for glial cells. The
Cytotox 96® enzymatic assay (Promega, France) was used
to quantify necrosis by measuring LDH release into the
culture medium. The percentage total lysis was calculated
as follows: % = [(X-B)/(T-B)] × 100, where B (baseline) is
a control corresponding to LDH spontaneously produced
by glial cells incubated with concentrated LB (10 μL/mL
culture medium), T is a positive control (100%) corre-
sponding to the amount of LDH detected in the culture
medium after total lysis of the cell population by Triton X-
100 (9% (v/v) in water) treatment and X is the amount of
LDH detected in the culture medium of the sample tested.
The assay was sensitive enough to measure LDH concen-
trations equivalent to the lysis of 1% of the cell popula-
tion.
Hemolysis assays
The hemolytic potentials of bacterial culture supernatants
were measured by a technique derived from that described
by Dacheux et al. [49]. Briefly, sheep erythrocytes
obtained from Eurobio (France) were washed three times
in PBS (pH 7.2, 0.8% NaCl, 0.02% KCl, 0.17% Na2HPO4,
0.8% KH2PO4) and resuspended in RPMI-1640 medium
(Sigma) to a final concentration of 2% (cell volume/
medium volume). Bacteria were grown in LB, and the
enzymatic activity of the culture supernatant was assessed.
Samples were obtained from bacteria cultured at various
temperatures (8, 17, 28 or 37°C) for 15 generations. The
bacterial cultures were centrifuged and the supernatants
collected and sterilized by passage through a Millipore fil-
ter with 0.22 μm pores. For hemolysis assays, we com-
bined 600 μL of a 2% suspension of red blood cells
(RBCs) with 600 μL of filtered supernatant and incubated
this mixture for 2 h at 37°C. The suspension was centri-
fuged at 10,000 g for 8 min at 4°C, and hemoglobin
release was assessed by determining absorbance at 540
nm. The percentage (%) of cells lysed was calculated as
follows: % = [(X-B)/(T-B)] × 100. B (baseline) is a negative
control corresponding to RBCs incubated with 600 μL
sterile LB and T is a positive control corresponding to the
total lysis obtained by incubating RBCs in LB supple-
mented with 0.1% SDS (final concentration). X is the
absorbance value for the sample analyzed. All experi-
ments were performed at least three times in triplicate.
D609 was obtained from Sigma and used at a final con-
centration of 1 mM.
Protease and LPS assays
Protease assays were carried out with supernatants from
bacteria cultured for 15 generations, as described by Hel-
lio et al. [13]. LPS levels were quantified by determining 2-
keto-3-deoxyoctulonic acid (KDO) concentration, as
described by Karkhanis et al.[50].BMC Microbiology 2008, 8:189 http://www.biomedcentral.com/1471-2180/8/189
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Biosurfactant production
Biosurfactant production was assessed by the drop-col-
lapse test mainly as described previously [51]. Drops of
Volvic water were dispensed into a Petri dish with a poly-
styrene platform. Drops of culture supernatant were
added to the drops of water. If the culture broth contained
biosurfactant, the droplets of water collapsed.
Gel electrophoresis conditions, zymogram methods and 
amino-acid sequencing
Sodium dodecyl sulfate polyacrylamide gel electrophore-
sis (SDS-PAGE) was carried out as described by Laemmli
[52]. For a zymogram on egg-yolk agar, a silver-stained
SDS-PAGE gel was washed three times in water and placed
directly on an egg-yolk agar plate. After overnight incuba-
tion at 37°C, lecithinase activity was detected as an
opaque band corresponding to lecithin hydrolysis. For N-
terminal amino-acid sequencing, the supernatant proteins
were transferred to PVDF membranes and subjected to
Edman degradation in an Applied Biosytems 492 auto-
mated protein sequencer.
Motility assays
Motility assays were performed as described [53], with
light modifications. Each strain was incubated on LB agar
plates for 24 h at 28°C. Plates of LB medium solidified
with 0.3% agar (for the assessment of swimming motility)
were inoculated by stabbing colonies with a toothpick
and inserting the end of the toothpick just below the sur-
face of the agar. Three colonies were picked from three
plates and incubated at 28°C until a migration halo
appeared. We then spotted 5 μL of 3 independent suspen-
sions of each strain onto LB medium plus 0.6% agar
(swarming motility) and the plates were incubated until a
migration halo appeared.
Static biofilm assay and quantification
Biofilm assay was adapted from the method of O'Toole
and Kolter [54]. Bacteria were plated on LB agar plates and
incubated for 24 h at 28°C. Three independent LB suspen-
sions of each strain were adjusted to an OD580 of 0.4. We
added 100 μL aliquots of each suspension to the wells of
96-well microtiter plates, at least in triplicate. The negative
control consisted of LB broth without bacteria. Plates were
incubated for 24 h at 37°C without shaking. The bacterial
cells bound to the wall of the wells were then stained with
0.1% crystal violet and the remaining crystal violet was
then quantified by treatment with 150 μL of 1% SDS and
the determination of absorbance at 595 nm with a micro-
titer plate reader (Model 680XR, Biorad).
Electron microscopy
Early exponential growth phase bacteria were fixed by
incubation in an equal volume of modified Karnofsky
buffer (2.5% glutaraldehyde, 1% paraformaldehyde in
0.15 M sodium cacodylate buffer) at least 10 minutes and
washed in phosphate buffer (0.1 M; pH 8). Nickel-coated
copper grids (200 mesh) were floated on a drop of washed
bacteria, rinsed in ultrapure grade water, and negatively
stained with 0.5% (wt/vol) phosphotungstic acid (5 to 10
s). Electron microscopy was performed with a Philips
CM10 transmission electron microscope.
Oligonucleotides and polymerase chain reactions
Five colonies of each strain were suspended in 600 μL ster-
ile ultrapure water. The suspension (1 μL) was then used
for PCR with template DNA from bacterial colonies. PCR
was carried out in a 50 μL reaction volume, in a GeneAmp
PCR system 2400 (Perkin-Elmer Corporation, USA). Each
reaction mixture contained DNA template, 1.25 μL Taq
polymerase (GMP grade, Roche Diagnostics Gmbh, Ger-
many),Taq  PCR buffer (GMP grade, Roche Diagnostics
Gmbh, Germany), 0.2 μL primers and 125 μM of each
deoxyribonucleoside triphosphate. After initial denatura-
tion for five minutes at 94°C, the reaction mixture was
subjected to 30 cycles of 1 minute at 94°C, 30 s at 54°C
and 1.5 minutes at 72°C, followed by a final 7-minute
extension at 72°C. The primers used for PCR were pur-
chased from Proligo (France). The complete plcC  gene
sequence (approximately 1.2 kb) was amplified with
PLC1 (5'-ATGTCAGGTCTTGAACTCGCA-3') and PLC2
(5'-TTAGTTGGCGGGTTGGTTT-3'). The use of PLC0 (5'-
GGTGGAAATCACCCTGG-3') with PLC2 amplified the
plcC gene and its promoter (approximately 1.5 kb). GntR
(5'-CCGAGTCGGCGATCATG-3') was used with PLC (5'-
GCAAGGACGTCAACGATTTG-3') to amplify the 3' flank-
ing region of plcC.
Sequence determination and analysis
The 1.2 kb or 1.5 kb PCR fragment was isolated with a
DNA gel extraction kit (Genomics/Millipore) and cloned
with the pMOSBlue Blunt-ended Cloning Kit (Amer-
sham/Biosciences). MOS cells were transformed and, after
blue/white colony screening, clones were picked and plas-
mid DNA was isolated with the QIAprep Spin Miniprep
Kit (Qiagen). Plasmids were checked by digestion with
HindIII/AvaI and sequenced by Genome Express (France).
The predicted protein sequence of MFN1032 PlcC was for
BLAST queries http://www.ncbi.nlm.nih.gov/BLAST/.
Construction of a plcC-overexpressing MFN1032 clone: 
MFN1036
The 1.5 kb PCR fragment was inserted into the pMOSBlue
vector. The 1.5 kb AvaI/HindIII fragment was then trans-
ferred to the pUCP2O shuttle vector to construct pMF36
[55]. MFN1032 was electroporated with pMF36. Positive
colonies were selected based on mezlocillin resistance and
lecithin degradation on an egg-yolk agar plate. Clones
were checked by plasmid DNA isolation with the QIAprep
Spin Miniprep Kit (Qiagen), followed by enzymatic diges-BMC Microbiology 2008, 8:189 http://www.biomedcentral.com/1471-2180/8/189
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tion. The strain obtained, MFN1036, was cultured in LB
with a final concentration of 500 μg/mL mezlocillin.
Construction of a plcC-negative mutant, MFN1037, and 
the complemented MFN1038 strain
EcoRI/HindIII digestion of the 1.2 kb PCR fragment gener-
ated a 1 kb fragment corresponding to a 3'-deleted plcC
gene. This fragment was inserted into the transferable sui-
cide plasmid pME3087 [56], creating pMF1034 in
Escherichia coli DH5αMCR cells. Plasmids were isolated
with the QIAprep Spin Miniprep Kit (Qiagen), checked by
digestion with HindIII/EcoRI and transferred into the E.
coli S17.1 conjugative strain [57]. MFN1032 cells were
conjugated with the S17.1 pMF1034 strain and selected
for resistance to tetracycline and ampicillin. Clones were
tested by PCR with PLC0 and PLC2 probes to confirm dis-
ruption of the plcC  gene. MFN1037 (plcC-deficient
MFN1032) had no1.5 kb fragment corresponding to the
plcC gene under the control of its own promoter. This
strain also had an attenuated egg-yolk degradation pheno-
type. It was cultured in LB with a final concentration of 40
μg/mL tetracycline. Complementation of the mutation
was obtained by electroporating MFN1037 with pMF36
(strain MFN1038). Clones were selected for resistance to
mezlocillin and tetracycline and egg-yolk degradation
phenotype, and were checked by plasmid DNA isolation
with the QIAprep Spin miniprep Kit (Qiagen), followed
by enzymatic digestion.
Authors' contributions
GR wrote the manuscript and analyzed most of the data.
AM participated in the molecular genetic studies, carried
out the sequence comparison and participated in the
design of the study and the manuscript. JG was involved
in the swimming motility assays and flagellin identifica-
tion. WV and OL carried out the glial cell cytotoxicity
assays. MF helped to design and write the manuscript. NO
was involved in designing the study. All authors read and
approved the final manuscript.
Acknowledgements
This work was supported by the Région Haute-Normandie.
References
1. Whyte A, Lafong C, Malone J, Golda B: Contaminated lithium
heparin bottles as a source of pseudobacteremia.  J Hosp Infect
1999, 42:342-343.
2. Spiers AJ, Buckling A, Rainey PB: The causes of Pseudomonas
diversity.  Microbiology 2000, 146:2345-2350.
3. Von Graevenitz A: Clinical microbiology on unsual Pseu-
domonas species.  Progress in Clinical Pathology 1973, 5:185-218.
4. Bernstein DI, Lummus ZL, Santilli G, Siskosky J, Bernstein IL:
Machine operator's lung. A hypersensitivity pneumonitis dis-
order associated with exposure to metalworking fluid aero-
sols.  Chest 1995, 108(3):636-641.
5. Kaushal ML, Grover PS, Gupta ML: Non-fermenters in urinary
tract infection.  J Assoc Physicians India 1998, 46(9):798-800.
6. Hsueh P, Teng L, Pan H, Chen Y, Sun C, Ho S, Luh K: Outbreak of
Pseudomonas fluorescens bacteremia among oncology
patients.  J Clin Microbiol 1998, 36:2914-2917.
7. Chapalain A, Rossignol G, Lesouhaitier O, Merieau A, Gruffaz C, Gue-
rillon J, Meyer JM, Orange N, Feuilloley MGJ: Comparative study
of seven fluorescent pseudomonad clinical isolates.  Can J
Microbiol 2008, 54(1):19-27.
8. Picot L, Abdelmoula SM, Merieau A, Leroux P, Cazin L, Orange N,
Feuilloley MG: Pseudomonas fluorescens as a potential patho-
gen: adherence to nerve cells.  Microbes Infect 2001,
3(12):985-995.
9. Feuilloley MGJ, Mezghani-Abdelmoula S, Picot L, Lesouhaitier O, Mer-
ieau A, Guerillon J, Orange N: Involvement of Pseudomonas and
related species in central nervous system infections.  Recent
Adv Dev Microbiol 2003, 7:55-71.
10. Picot L, Mezghani-Abdelmoula S, Chevalier S, Merieau A, Lesouhaitier
O, Guerillon J, Cazin L, Orange N, Feuilloley MG: Regulation of the
cytotoxic effects of Pseudomonas fluorescens by growth tem-
perature.  Res Microbiol 2004, 155(1):39-46.
11. Lazdunski A: Pseudomonas aeruginosa: a model of choice for
the study of opportunistic pathogen.  Ann Fr Anesth Reanim 2003,
22:523-526.
12. Mohr CD, Tomich M, Herfst CA: Cellular aspects of Burkholderia
cepacia infection.  Microbes Infect 2001, 3(5):425-435.
13. Hellio FC, Orange N, Guespin-Michel JF: Growth temperature
controls the production of a single extracellular protease by
Pseudomonas fluorescens MF0, in the presence of various
inducers.  Res Microbiol 1993, 144(8):617-625.
14. Dieckelmann M, Johnson LA, Beacham IR: The diversity of lipases
from psychrotrophic strains of Pseudomonas: a novel lipase
from a highly lipolytic strain of Pseudomonas fluorescens.  J
Appl Microbiol 1998, 85(3):527-536.
15. Preuss I, Kaiser I, Gehring U: Molecular characterization of a
phosphatidylcholine-hydrolyzing phospholipase C.  Eur J Bio-
chem 2001, 268(19):5081-5091.
16. Ivanov A, Titball RW, Kostadinova S: Characterisation of a phos-
pholipase C produced by Pseudomonas fluorescens.  New Micro-
biol 1996, 19(2):113-121.
17. Sacherer P, Defago G, Haas D: Extracellular protease and phos-
pholipase C are controlled by the global regulatory gene gac
A in the biocontrol strain Pseudomonas fluorescens CHA0.
FEMS Microbiol Lett 1994, 116(2):155-160.
18. Crevel I, U S, Carne A, Katan M: Purification and properties of
zinc-metallophospholipase C from Pseudomonas fluorescens.
Eur J Biochem 1994, 224(3):845-852.
19. Doi O, Nojima S: Phospholipase C from Pseudomonas fluores-
cens.  Biochim Biophys Acta 1971, 248(2):234-244.
20. Songer JG: Bacterial phospholipases and their role in viru-
lence.  Trends Microbiol 1997, 5(4):156-161.
21. Titball RW: Bacterial phospholipases C.  Microbiol Rev 1993,
57(2):347-366.
22. Schmiel DH, Miller VL: Bacterial phospholipases and pathogen-
esis.  Microbes Infect 1999, 1(13):1103-1112.
23. Ostroff RM, Vasil AI, Vasil ML: Molecular comparison of a non-
hemolytic and a hemolytic phospholipase C from Pseu-
domonas aeruginosa.  J Bacteriol 1990, 172(10):5915-5923.
24. Montes L-R, Ibarguren M, Goni FM, Stonehouse MJ, Vasil MI, Alonso
A: Leakage-free membrane fusion induced by the hydrolytic
activity of PlcHR2, a novel phospholipase C/sphingomyeli-
nase from Pseudomonas aeruginosa.  Biochim Biophys Acta 2007,
1768:2354-2372.
25. Amtmann E: The antiviral, antitumoural xanthate D609 is a
competitive inhibitor of phosphatidylcholine-specific phos-
pholipase C.  Drugs Exp Clin Res 1996, 22(6):287-294.
26. Stonehouse MJ, Cota-Gomez A, Parker SK, Martin WE, Hankin JA,
Murphy RC, Chen W, Lim KB, Hackett M, Vasil AI, et al.: A novel
class of microbial phosphocholine-specific phospholipases C.
Mol Microbiol 2002, 46(3):661-676.
27. Rigali S, Derouaux A, Giannotta F, Dusart J: Subdivision of the
helix-turn-helix GntR family of bacterial regulators in the
FadR, HutC, MocR, and YtrA subfamilies.  J Biol Chem 2002,
277(15):12507-12515.
28. Compant S, Brion D, Jerzy N, Christophe C, Barka EA: Use of Plant
Growth-Promoting Bacteria for Biocontrol of Plant Dis-
eases: Principles, Mechanisms of Action, and Future Pros-
pects.  Applied and Environmental Microbiology 2005, 71:4951-4959.
29. Alonso A, Rojo F, Martinez JL: Environmental and clinical iso-
lates of Pseudomonas aeruginosa show pathogenic and bio-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Microbiology 2008, 8:189 http://www.biomedcentral.com/1471-2180/8/189
Page 14 of 14
(page number not for citation purposes)
degradative properties irrespective of their origin.  Environ
Microbiol 1999, 1(5):421-430.
30. Morales G, Wiehlmann L, Gudowius P, van Delden C, Tummler B,
Martinez JL, Rojo F: Structure of Pseudomonas aeruginosa pop-
ulations analyzed by single nucleotide polymorphism and
pulse-field gel electrophoresis genotyping.  J Bacteriol 2004,
186(13):4228-4237.
31. Alouf J: Les toxines bactériennes membranolytiques.  Bull Soc
Fr Microbiol 2000, 15(2):104-110.
32. Sonoki S, Ikezawa H: Studies on phospholipase C from Pseu-
domonas aureofaciens. I. Purification and some properties of
phospholipase C.  Biochim Biophys Acta 1975, 403(2):412-424.
33. Barker AP, Vasil AI, Filloux A, Ball G, Wilderman PJ, Vasil ML: A
novel extracellular phospholipase C of Pseudomonas aerugi-
nosa is required for phospholipid chemotaxis.  Mol Microbiol
2004, 53(4):1089-1098.
34. Voulhoux R, Ball G, Ize B, Vasil ML, Lazdunski A, Wu LF, Filloux A:
Involvement of the twin-arginine translocation system in
protein secretion via the type II pathway.  Embo J 2001,
20(23):6735-6741.
35. Rossier O, Cianciotto NP: The Legionella pneumophila tatB gene
facilitates secretion of phospholipase C, growth under iron-
limiting conditions, and intracellular infection.  Infect Immun
2005, 73(4):2020-2032.
36. Givskov M, Eberl L, Christiansen G, Benedik MJ, Molin S: Induction
of phospholipase- and flagellar synthesis in Serratia liquefa-
ciens  is controlled by expression of the flagellar master
operon flhD.  Mol Microbiol 1995, 15(3):445-454.
37. Schmiel DH, Young GM, Miller VL: The Yersinia enterocolitica
phospholipase gene yplA is part of the flagellar regulon.  J Bac-
teriol 2000, 182(8):2314-2320.
38. Young GM, Schmiel DH, Miller VL: A new pathway for the secre-
tion of virulence factors by bacteria: the flagellar export
apparatus functions as a protein-secretion system.  Proc Natl
Acad Sci USA 1999, 96(11):6456-6461.
39. Young BM, Young GM: YplA is exported by the Ysc, Ysa, and
flagellar type III secretion systems of Yersinia enterocolitica.  J
Bacteriol 2002, 184(5):1324-1334.
40. Jacob-Dubuisson F, Fernandez R, Coutte L: Protein secretion
through autotransporter and two-partner pathways.  Biochim
Biophys Acta 2004, 1694(1–3):235-257.
41. Warren SM, Young GM: An amino-terminal secretion signal is
required for YplA export by the Ysa, Ysc, and flagellar type
III secretion systems of Yersinia enterocolitica biovar 1B.  J Bac-
teriol 2005, 187(17):6075-6083.
42. Linares JF, Gustafsson I, Baquero F, Martinez JL: Antibiotics as
intermicrobial signaling agents instead of weapons.  Proc Natl
Acad Sci USA 2006, 103(51):19484-19489.
43. Kaufman M, Thomas R: Emergence of complex behaviour from
simple circuit structures.  C R Biol 2003, 326(2):205-214.
44. Rigali S, Schlicht M, Hoskisson P, Nothaft H, Merzbacher M, Joris B,
Titgemeyer F: Extending the classification of bacterial tran-
scription factors beyond the helix-turn-helix motif as an
alternative approach to discover new cis/trans relationships.
Nucleic Acids Res 2004, 32(11):3418-3426.
45. Guespin-Michel JF, Polack B, Merieau A: Bacterial adaptation and
epigenesis.  Recent research and Developments in Microbiology 2003,
7:289-305.
46. Filopon D, Merieau A, Bernot G, Comet JP, Leberre R, Guery B, Pol-
ack B, Guespin-Michel J: Epigenetic acquisition of inducibility of
type III cytotoxicity in P. aeruginosa.  BMC Bioinformatics 2006,
7:272.
47. Holloway BW, Krishnapillai V, Morgan AF: Chromosomal genetics
of Pseudomonas.  Microbiol Rev 1979, 43:73-102.
48. Burini JF, Gugi B, Merieau A, Guespin-Michel JF: Lipase and acidic
phosphatase from the psychrotrophic bacterium Pseu-
domonas fluorescens: two enzymes whose synthesis is regu-
lated by the growth temperature.  FEMS Microbiol Lett 1994,
122(1–2):13-18.
49. Dacheux D, Attree I, Toussaint B: Expression of ExsA in trans
confers type III secretion system-dependent cytotoxicity on
noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.
Infect Immun 2001, 69(1):538-542.
50. Karkhanis YD, Zeltner JY, Jackson JJ, Carlo DJ: A new and
improved microassay to determine 2-keto-3-deoxyoctonate
in lipopolysaccharide of Gram-negative bacteria.  Anal Biochem
1978, 85(2):595-601.
51. Youssef NH, Duncan KE, Nagle DP, Savage KN, Knapp RM, McIner-
ney MJ: Comparison of methods to detect biosurfactant pro-
duction by diverse microorganisms.  J Microbiol Methods 2004,
56(3):339-347.
52. Laemmli UK, Molbert E, Showe M, Kellenberger E: Form-deter-
mining function of the genes required for the assembly of the
head of bacteriophage T4.  J Mol Biol 1970, 49(1):99-113.
53. Deziel E, Comeau Y, Villemur R: Initiation of biofilm formation
by Pseudomonas aeruginosa 57RP correlates with emergence
of hyperpiliated and highly adherent phenotypic variants
deficient in swimming, swarming, and twitching motilities.  J
Bacteriol 2001, 183(4):1195-1204.
54. O'Toole GA, Kolter R: Initiation of biofilm formation in Pseu-
domonas fluorescens WCS365 proceeds via multiple, conver-
gent signalling pathways: a genetic analysis.  Mol Microbiol 1998,
28(3):449-461.
55. West SE, Schweizer HP, Dall C, Sample AK, Runyen-Janecky LJ: Con-
struction of improved Escherichia-Pseudomonas shuttle vec-
tors derived from pUC18/19 and sequence of the region
required for their replication in Pseudomonas aeruginosa.
Gene 1994, 148(1):81-86.
56. Schnider U, Keel C, Voisard C, Defago G, Haas D: Tn5-directed
cloning of pqq genes from Pseudomonas fluorescens CHA0:
mutational inactivation of the genes results in overproduc-
tion of the antibiotic pyoluteorin.  Appl Environ Microbiol 1995,
61(11):3856-3864.
57. Simon RPU, Pehle A: A broad host range mobilization system
for in vitro genetic engineering: transposon mutagenesis in
Gram-negative bacteria.  biotechology 1983, 1:784-790.